methylprednisolone sodium succinate · Medicine question

What fetal growth risk is associated with prolonged or repeated use of Solu-Medrone (methylprednisolone sodium succinate) during pregnancy?

Name: What fetal growth risk is associated with prolonged or repeated use of Solu-Medrone (methylprednisolone sodium succinate) during pregnancy?
Published: 2026-11-08T01:57:02.184Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Prolonged or repeated use of Solu-Medrone (methylprednisolone sodium succinate) during pregnancy may increase the risk of intra-uterine growth retardation.

Sources for this answer

Solu-Medrone 500mg for injectionPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 24Document updated 5 November 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about methylprednisolone sodium succinate